{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:30:59Z","timestamp":1789500659084,"version":"build-2803163510"},"reference-count":24,"publisher":"Central Research Institute for Epidemiology","issue":"3","license":[{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["virusjour.crie.ru"],"crossmark-restriction":false},"short-container-title":["Problems of Virology"],"abstract":"<jats:p>Objective. To analyze the age-related characteristics of the contribution of influenza viruses, RSV, SARS-CoV-2, other pathogens to the development of severe acute respiratory infections (SARI) in children with an assessment of the disease severity depending on its etiology and epidemic period.\r\nMaterials and methods. SARI monitoring was carried out over six consecutive epidemic seasons, starting from 2018\u20132019 in 9 infectious hospitals of three cities of Russia with an assessment of the disease severity depending on its etiology.\r\nResults. Among all hospitalized children, the proportion of children hospitalized with laboratory-confirmed influenza from 2018 to 2020 ranged from 25.7% to 44.7%, and for RSV infection from 25.7% to 26.8%. However, during the peak of the pandemic, these rates dropped significantly to 0.3% and 1.7%, respectively. In the subsequent three seasons (2021\u20132024), laboratory-confirmed influenza among hospitalized children was registered in 4.5\u201320.2% of cases, while RSV infection was identified in 13.4\u201324.1% of cases, accompanied by a shift in viral subgroups. RSV infections were most severe during the 2022\u20132023 season, presenting in some cases with hyperthermia, hypoxia, dyspnea, and altered consciousness. Among hospitalized children, the proportion with COVID-19 was relatively low in 2020\u20132021 (0.8\u20132.4%) but increased significantly to 10.6%\u201313.6% following the emergence of the Omicron variant in 2022, before decreasing again in subsequent years. The main genetic lineages of SARS-CoV-2 circulating in the Russian Federation are presented.\r\nConclusion. Influenza and RSV viruses were predominant among viral pathogens identified in hospitalized children aged \u2264 2 years. COVID-19 cases among children were relatively rare and generally less severe compared to RSV and rhinovirus infections.<\/jats:p>","DOI":"10.36233\/0507-4088-313","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T13:27:14Z","timestamp":1753104434000},"page":"254-266","update-policy":"https:\/\/doi.org\/10.36233\/0372-9311-crossmark","source":"Crossref","is-referenced-by-count":2,"title":["Impact of COVID-19 pandemic on the etiology and severity of respiratory viral infections in children"],"prefix":"10.36233","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9671-0629","authenticated-orcid":false,"given":"Anna \u0410.","family":"Sominina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6174-0836","authenticated-orcid":false,"given":"Darya M.","family":"Danilenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1733-1255","authenticated-orcid":false,"given":"Andrey B.","family":"Komissarov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3558-3261","authenticated-orcid":false,"given":"Artem V.","family":"Fadeev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1465-5548","authenticated-orcid":false,"given":"Ksenia S.","family":"Komissarova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1499-9957","authenticated-orcid":false,"given":"Maria M.","family":"Pisareva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3050-1936","authenticated-orcid":false,"given":"Tamila D.","family":"Musayeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9970-3325","authenticated-orcid":false,"given":"Veronika A.","family":"Eder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6888-6848","authenticated-orcid":false,"given":"Tatiana P.","family":"Levanyuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1765-2799","authenticated-orcid":false,"given":"Kirill A.","family":"Stolyarov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9146-0816","authenticated-orcid":false,"given":"Vera Z.","family":"Krivitskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2258-4679","authenticated-orcid":false,"given":"Ekaterina R.","family":"Petrova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1229-171X","authenticated-orcid":false,"given":"Olga I.","family":"Afanasyeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2887-0126","authenticated-orcid":false,"given":"Veronika S.","family":"Timonina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8762-6724","authenticated-orcid":false,"given":"Elena V.","family":"Obraztsova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1934-7288","authenticated-orcid":false,"given":"Ekaterina G.","family":"Golovacheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2382-9172","authenticated-orcid":false,"given":"Elena A.","family":"Dondurey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2004-0977","authenticated-orcid":false,"given":"Evgenya V.","family":"Lelenkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1931-2026","authenticated-orcid":false,"given":"Olga G.","family":"Kurskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1880-8708","authenticated-orcid":false,"given":"Alexander M.","family":"Shestopalov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3643-7354","authenticated-orcid":false,"given":"Dmitry A.","family":"Lioznov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"22004","published-online":{"date-parts":[[2025,7,21]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Puig-Barber\u00e0 J., Tormos A., Trushakova S., Sominina A., Pisareva M., Ciblak M.A., et al. The Global Influenza Hospital Surveillance Network (GIHSN): a new platform to describe the epidemiology of severe influenza. Influenza Other Respir. Viruses. 2015; 9(6): 277\u201386. https:\/\/doi.org\/10.1111\/irv.12335","DOI":"10.1111\/irv.12335"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Puig-Barber\u00e0 J., Mira-Iglesias A., Burtseva E., Cowling B.J., Serhat U., Ruiz-Palacios G.M., et al. Influenza epidemiology and influenza vaccine effectiveness during the 2015-2016 season: results from the Global Influenza Hospital Surveillance Network. BMC Infect. Dis. 2019; 19(1): 415. https:\/\/doi.org\/10.1186\/s12879-019-4017-0","DOI":"10.1186\/s12879-019-4017-0"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Baselga-Moreno V., Trushakova S., McNeil S., Sominina A., Nunes M.C., Draganescu A., et al. Influenza epidemiology and influenza vaccine effectiveness during the 2016\u20132017 season in the Global Influenza Hospital Surveillance Network (GIHSN). BMC Public Health. 2019; 19(1): 487. https:\/\/doi.org\/10.1186\/s12889-019-6713-5","DOI":"10.1186\/s12889-019-6713-5"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Puig-Barber\u00e0 J., Tormos A., Sominina A., Burtseva E., Launay O., Ciblak M.A., et al. First-year results of the Global Influenza Hospital Surveillance Network: 2012-2013 Northern hemisphere influenza season. BMC Public Health. 2014; 14: 564. https:\/\/doi.org\/10.1186\/1471-2458-14-564","DOI":"10.1186\/1471-2458-14-564"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Puig-Barber\u00e0 J., Burtseva E., Yu H., Cowling B.J., Badur S., Kyncl J., et al. Influenza epidemiology and influenza vaccine effectiveness during the 2014\u20132015 season: annual report from the Global Influenza Hospital Surveillance Network. BMC Public Health. 2016; 16(Suppl. 1): 757. https:\/\/doi.org\/10.1186\/s12889-016-3378-1","DOI":"10.1186\/s12889-016-3378-1"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Simon B., Pichon M., Valette M., Burfin G., Richard M., Lina B., et al. Whole genome sequencing of A(H3N2) influenza viruses reveals variants associated with severity during the 2016\u20132017 season. Viruses. 2019; 11(2): 108. https:\/\/doi.org\/10.3390\/v11020108","DOI":"10.3390\/v11020108"},{"key":"ref7","unstructured":"WHO. Recommended composition of influenza virus vaccines for use in the 2024\u20132025 northern hemisphere influenza season; 2024. Available at: https:\/\/who.int\/news\/item\/23-02-2024-recommendations-announced-for-influenza-vaccine-composition-for-the-2024-2025-northern-hemisphere-influenza-season"},{"key":"ref8","unstructured":"WHO. Global influenza strategy 2019\u20132030; 2019. Available at: https:\/\/who.int\/publications\/i\/item\/9789241515320"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Sominina A.A., Danilenko D.M., Komissarov A.B., Pisareva M.M., Musaeva T.D., Stolyarov K.A., et al. Changes in the etiological structure of severe acute respiratory viral infections in children and adults under the influence of the COVID-19 pandemic. Zhurnal mikrobiologii, epidemiologii i immunobiologii. 2024; 101(3): 327\u201341. https:\/\/doi.org\/10.36233\/0372-9311-532 (in Russian)","DOI":"10.36233\/0372-9311-532"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Burtseva E.I., Kolobukhina L.V., Voronina O.L., Ignatjeva A.V., Mukasheva E.A., Panova A.D., et al. Features of the circulation of ARVI pathogens during of emergence and widespread of SARS-CoV-2 in the 2018\u20132021. Epidemiologiya i vaktsinoprofilaktika. 2022; 21(4): 16\u201325. https:\/\/doi.org\/10.31631\/2073-3046-2022-21-4-16-26 https:\/\/elibrary.ru\/rnyfoi (in Russian)","DOI":"10.31631\/2073-3046-2022-21-4-16-26"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Burtseva E.I., Kolobukhina L.V., Panova A.D., Mukasheva E.A., Krasnoslobodtsev K.G., Kirillova E.S., et al. Properties of influenza viruses that caused epidemic increases in morbidity in Russia and countries of the world during 2022-2023. The effectiveness of vaccine prophylaxis. Voprosy virusologii. 2024; 69(1): 42\u201355. https:\/\/doi.org\/10.36233\/0507-4088-211 (in Russian)","DOI":"10.36233\/0507-4088-211"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Sominina A.A., Danilenko D.M., Stolyarov K.A., Karpova L.S., Bakaev M.I., Levanyuk T.P., et al. Interference of SARS-CoV-2 with other respiratory viral infections agents during pandemic. Epidemiologiya i vaktsinoprofilaktika. 2021; 20(4): 28\u2013139. https:\/\/doi.org\/10.31631\/2073-3046-2021-20-4-28-39 https:\/\/elibrary.ru\/cdrnsj (in Russian)","DOI":"10.31631\/2073-3046-2021-20-4-28-39"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Olsen S.J., Azziz-Baumgartner E., Budd A.P., Brammer L., Sullivan S., Pineda R.F., et al. Decreased influenza activity during the COVID-19 pandemic \u2013 United States, Australia, Chile, and South Africa, 2020. MMWR Morb. Mortal. Wkly Rep. 2020; 69(37): 1305\u20139. https:\/\/doi.org\/10.15585\/mmwr.mm6937a6","DOI":"10.15585\/mmwr.mm6937a6"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Adlhoch C., Mook P., Lamb F., Ferland L., Melidou A., Amato-Gauci A.J., et al. Very little influenza in the WHO European Region during the 2020\/21 season, weeks 40 2020 to 8 2021. Euro Surveill. 2021; 26(11): 2100221. https:\/\/doi.org\/10.2807\/1560-7917.ES.2021.26.11.2100221","DOI":"10.2807\/1560-7917.ES.2021.26.11.2100221"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Mesl\u00e9 M.M.I., Sinnathamby M., Mook P., Pebody R., Lakhani A., Zambon M., et al. Seasonal and inter-seasonal RSV activity in the European Region during the COVID-19 pandemic from autumn 2020 to summer 2022. Influenza Other Respir. Viruses. 2023; 17(11): e13219. https:\/\/doi.org\/10.1111\/irv.13219","DOI":"10.1111\/irv.13219"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Sominina A., Danilenko D., Komissarov A.B., Pisareva M., Fadeev A., Konovalova N., et al. Assessing the intense influenza A(H1N1)pdm09 epidemic and vaccine effectiveness in the post-COVID season in the Russian Federation. Viruses. 2023; 15(8): 1780. https:\/\/doi.org\/10.3390\/v15081780","DOI":"10.3390\/v15081780"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Cohen L.E., Hansen C.L., Andrew M.K., McNeil S.A., Vanhems P., Kyncl J., et al. Predictors of severity of influenza-related hospitalizations: results from the Global Influenza Hospital Surveillance Network (GIHSN). J. Infect. Dis. 2024; 229(4): 999\u20131009. https:\/\/doi.org\/10.1093\/infdis\/jiad303","DOI":"10.1093\/infdis\/jiad303"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Karpova L.S., Volik K.M., Stolyarov K.A., Popovtseva N.M., Stolyarova T.P., Sominina A.A., et al. Features of epidemic process of influenza a(h1n1)pdm09 and a(h3n2) in Russia from 2009 to 2017. Voprosy virusologii. 2018; 63(4): 177\u201384. https:\/\/doi.org\/10.18821\/0507-4088-2018-63-4-177-184 https:\/\/elibrary.ru\/ymvmwl (in Russian)","DOI":"10.18821\/0507-4088-2018-63-4-177-184"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Popova A.Yu., Smirnov V.S., Egorova S.A., Drozd I.V., Milichkina A.M., Dashkevich A.M., et al. Patterns in the development of collective immunity to SARS-CoV-2 during the COVID-19 pandemic. Meditsinskaya immunologiya. 2023; 25(4): 759\u201366. https:\/\/doi.org\/10.15789\/1563-0625-PIT-2867 (in Russian)","DOI":"10.15789\/1563-0625-PIT-2867"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Krivitskaya V.Z., Sintsova K.S., Petrova E.R., Sverlova M.V., Sorokin E.V., Tsareva T.R., et al. Genetic and antigenic characteristics of respiratory syncytial virus strains isolated in St. Petersburg in 2013\u20132016. Voprosy virusologii. 2017; 62(6): 273\u201382. https:\/\/doi.org\/10.18821\/0507-4088-2017-62-6-273-282 https:\/\/elibrary.ru\/zuqevd (in Russian)","DOI":"10.18821\/0507-4088-2017-62-6-273-282"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Schobel S.A., Stucker K.M., Moore M.L., Anderson L.J., Larkin E.K., Shankar J., et al. Respiratory Syncytial Virus whole-genome sequencing identifies convergent evolution of sequence duplication in the C-terminus of the G gene. Sci. Rep. 2016; 6: 26311. https:\/\/doi.org\/10.1038\/srep26311","DOI":"10.1038\/srep26311"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Rosas-Salazar C., Chirkova T., Gebretsadik T., Chappell J.D., Peebles R.S. Jr., Dupont W.D., et al. Respiratory syncytial virus infection during infancy and asthma during childhood in the USA (INSPIRE): a population-based, prospective birth cohort study. Lancet. 2023; 401(10389): 1669\u201380. https:\/\/doi.org\/10.1016\/S0140-6736(23)00811-5","DOI":"10.1016\/S0140-6736(23)00811-5"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Gilbert B.E., Patel N., Lu H., Liu Y., Guebre-Xabier M., Piedra P.A., et al. Respiratory syncytial virus fusion nanoparticle vaccine immune responses target multiple neutralizing epitopes that contribute to protection against wild-type and palivizumab-resistant mutant virus challenge. Vaccine. 2018; 36(52): 8069\u201378. https:\/\/doi.org\/10.1016\/j.vaccine.2018.10.073","DOI":"10.1016\/j.vaccine.2018.10.073"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Sun M., Lai H., Na F., Li S., Qiu X., Tian J., et al. Monoclonal antibody for the prevention of respiratory syncytial virus in infants and children: a systematic review and network meta-analysis. JAMA Netw. Open. 2023; 6(2): e230023. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.0023","DOI":"10.1001\/jamanetworkopen.2023.0023"}],"container-title":["Problems of Virology"],"original-title":[],"link":[{"URL":"https:\/\/virusjour.crie.ru\/jour\/article\/viewFile\/16745\/996","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/virusjour.crie.ru\/jour\/article\/viewFile\/16745\/996","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T13:29:10Z","timestamp":1753104550000},"score":1,"resource":{"primary":{"URL":"https:\/\/virusjour.crie.ru\/jour\/article\/view\/16745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,21]]},"references-count":24,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,7,21]]}},"URL":"https:\/\/doi.org\/10.36233\/0507-4088-313","relation":{},"ISSN":["2411-2097","0507-4088"],"issn-type":[{"value":"2411-2097","type":"electronic"},{"value":"0507-4088","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,21]]}}}